Rachna Khosla, SVP of Business Development at Amgen Inc. ($AMGN), made two open market sales of AMGN stock in the last year, totaling about $734,000. Her most recent sale occurred on November 12, 2025. These transactions rank 5,630th among 11,678 insiders, well below the average sale amount of $8.6 million across 6 transactions per seller on average. Khosla made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | AMGEN INC | $AMGN | Khosla Rachna | SVP, Business Development | F | Common Stock | 707 | $366.21 | 8,291.0000 | 538,800,000 | 7.86% | 0.00% |
| March 3, 2026 | AMGEN INC | $AMGN | Khosla Rachna | SVP, Business Development | A | Common Stock | 1876 | $0.00 | 8,972.0000 | 538,800,000 | 26.44% | 0.00% |
| Nov. 12, 2025 | AMGEN INC | $AMGN | Khosla Rachna | SVP, Business Development | S | Common Stock | 890 | $336.24 | 7,082.0000 | 538,500,000 | 11.16% | 0.00% |
| Nov. 5, 2025 | AMGEN INC | $AMGN | Khosla Rachna | SVP, Business Development | F | Common Stock | 226 | $296.70 | 7,972.0000 | 538,500,000 | 2.76% | 0.00% |
| June 5, 2025 | AMGEN INC | $AMGN | Khosla Rachna | SVP, Business Development | S | Common Stock | 1500 | $289.68 | 8,162.0000 | 536,900,000 | 15.52% | 0.00% |
| May 6, 2025 | AMGEN INC | $AMGN | Khosla Rachna | SVP, Business Development | A | Common Stock | 610 | $0.00 | 9,662.0000 | 536,900,000 | 6.74% | 0.00% |
| May 6, 2025 | AMGEN INC | $AMGN | Khosla Rachna | SVP, Business Development | A | Nqso (Right to Buy) | 3943 | $270.44 | 3,943.0000 | 536,900,000 | 9999.99% | 0.00% |
| May 2, 2025 | AMGEN INC | $AMGN | Khosla Rachna | SVP, Business Development | F | Common Stock | 110 | $283.78 | 9,156.0000 | 536,900,000 | 1.19% | 0.00% |
| May 2, 2025 | AMGEN INC | $AMGN | Khosla Rachna | SVP, Business Development | F | Common Stock | 104 | $283.78 | 9,052.0000 | 536,900,000 | 1.14% | 0.00% |
| April 30, 2025 | AMGEN INC | $AMGN | Khosla Rachna | SVP, Business Development | F | Common Stock | 74 | $288.56 | 9,266.0000 | 536,900,000 | 0.79% | 0.00% |
| March 17, 2025 | AMGEN INC | $AMGN | Khosla Rachna | SVP, Business Development | F | Common Stock | 489 | $313.71 | 9,340.0000 | 536,900,000 | 4.98% | 0.00% |
| March 3, 2025 | AMGEN INC | $AMGN | Khosla Rachna | SVP, Business Development | A | Common Stock | 1403 | $0.00 | 9,802.0000 | 536,900,000 | 16.70% | 0.00% |
| Nov. 5, 2024 | AMGEN INC | $AMGN | Khosla Rachna | SVP, Business Development | F | Common Stock | 212 | $316.91 | 8,383.0000 | 537,500,000 | 2.47% | 0.00% |
| May 7, 2024 | AMGEN INC | $AMGN | Khosla Rachna | SVP, Business Development | A | Common Stock | 532 | $0.00 | 8,559.0000 | 535,400,000 | 6.63% | 0.00% |
| May 7, 2024 | AMGEN INC | $AMGN | Khosla Rachna | SVP, Business Development | A | Nqso (Right to Buy) | 3461 | $300.30 | 3,461.0000 | 535,400,000 | 9999.99% | 0.00% |
| May 5, 2024 | AMGEN INC | $AMGN | Khosla Rachna | SVP, Business Development | F | Common Stock | 41 | $311.29 | 8,027.0000 | 535,400,000 | 0.51% | 0.00% |
| May 2, 2024 | AMGEN INC | $AMGN | Khosla Rachna | SVP, Business Development | F | Common Stock | 74 | $277.37 | 8,068.0000 | 535,400,000 | 0.91% | 0.00% |
| April 30, 2024 | AMGEN INC | $AMGN | Khosla Rachna | SVP, Business Development | F | Common Stock | 48 | $276.38 | 8,142.0000 | 535,400,000 | 0.59% | 0.00% |
| March 18, 2024 | AMGEN INC | $AMGN | Khosla Rachna | SVP, Business Development | F | Common Stock | 438 | $268.87 | 8,190.0000 | 535,400,000 | 5.08% | 0.00% |
| March 6, 2024 | AMGEN INC | $AMGN | Khosla Rachna | SVP, Business Development | A | Common Stock | 1256 | $0.00 | 8,597.0000 | 535,400,000 | 17.11% | 0.00% |
| Nov. 5, 2023 | AMGEN INC | $AMGN | Khosla Rachna | SVP, Business Development | F | Common Stock | 144 | $269.86 | 7,323.0000 | 534,000,000 | 1.93% | 0.00% |
| Nov. 5, 2023 | AMGEN INC | $AMGN | Khosla Rachna | SVP, Business Development | F | Common Stock | 173 | $269.86 | 7,467.0000 | 534,000,000 | 2.26% | 0.00% |
| May 5, 2023 | AMGEN INC | $AMGN | Khosla Rachna | SVP, Business Development | F | Common Stock | 39 | $231.89 | 7,581.0000 | 534,000,000 | 0.51% | 0.00% |
| May 3, 2023 | AMGEN INC | $AMGN | Khosla Rachna | SVP, Business Development | F | Common Stock | 57 | $235.97 | 7,620.0000 | 534,000,000 | 0.74% | 0.00% |
| May 2, 2023 | AMGEN INC | $AMGN | Khosla Rachna | SVP, Business Development | A | Nqso (Right to Buy) | 5016 | $0.00 | 5,016.0000 | 534,000,000 | 9999.99% | 0.00% |
| May 2, 2023 | AMGEN INC | $AMGN | Khosla Rachna | SVP, Business Development | A | Common Stock | 593 | $0.00 | 7,677.0000 | 534,000,000 | 8.37% | 0.00% |
| April 30, 2023 | AMGEN INC | $AMGN | Khosla Rachna | SVP, Business Development | F | Common Stock | 47 | $239.74 | 7,084.0000 | 534,000,000 | 0.66% | 0.00% |
| March 17, 2023 | AMGEN INC | $AMGN | Khosla Rachna | SVP, Business Development | F | Common Stock | 241 | $234.57 | 7,103.0000 | 534,000,000 | 3.28% | 0.00% |
| March 6, 2023 | AMGEN INC | $AMGN | Khosla Rachna | SVP, Business Development | A | Common Stock | 687 | $0.00 | 7,338.0000 | 534,000,000 | 10.33% | 0.00% |